Overview

Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
Therapeutic equivalence and safety study
Phase:
Phase 1
Details
Lead Sponsor:
Taro Pharmaceuticals USA
Treatments:
Dapsone